|
Myeloid Neoplasia
Citations 161-170 of 176 total displayed.
|
Past content
(since Jan 2009):
|
A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene
- Bin Yin, Ruud Delwel, Peter J. Valk, Margaret R. Wallace, Mignon L. Loh, Kevin M. Shannon, and David A. Largaespada
Blood 2009; 113: 1075-1085.
[Abstract]
[Full text]
[PDF]
RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia
- Won-Il Kim, Ilze Matise, Miechaleen D. Diers, and David A. Largaespada
Blood 2009; 113: 1086-1096.
[Abstract]
[Full text]
[PDF]
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors
- Pau Montesinos, Juan M. Bergua, Edo Vellenga, Chelo Rayón, Ricardo Parody, Javier de la Serna, Angel León, Jordi Esteve, Gustavo Milone, Guillermo Debén, Concha Rivas, Marcos González, Mar Tormo, Joaquín Díaz-Mediavilla, Jose D. González, Silvia Negri, Elena Amutio, Salut Brunet, Bob Lowenberg, and Miguel A. Sanz
Blood 2009; 113: 775-783.
[Abstract]
[Full text]
[PDF]
Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia
- Pamela S. Becker, Kenneth J. Kopecky, Adrianne N. Wilks, Sylvia Chien, John M. Harlan, Cheryl L. Willman, Stephen H. Petersdorf, Derek L. Stirewalt, Thalia Papayannopoulou, and Frederick R. Appelbaum
Blood 2009; 113: 866-874.
[Abstract]
[Full text]
[PDF]
Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib
- Agnes S. M. Yong, Keyvan Keyvanfar, Nancy Hensel, Rhoda Eniafe, Bipin N. Savani, Maria Berg, Andreas Lundqvist, Sharon Adams, Elaine M. Sloand, John M. Goldman, Richard Childs, and A. John Barrett
Blood 2009; 113: 875-882.
[Abstract]
[Full text]
[PDF]
RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis
- Ming Yan, Eun-Young Ahn, Scott W. Hiebert, and Dong-Er Zhang
Blood 2009; 113: 883-886.
[Abstract]
[Full text]
[PDF]
Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD
- Andrew J. Mhyre, A. Mario Marcondes, Emily Y. Spaulding, and H. Joachim Deeg
Blood 2009; 113: 649-658.
[Abstract]
[Full text]
[PDF]
Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines
- Taichun Qin, Jaroslav Jelinek, Jiali Si, Jingmin Shu, and Jean-Pierre J. Issa
Blood 2009; 113: 659-667.
[Abstract]
[Full text]
[PDF]
In vivo expansion of cells expressing acquired CSF3R mutations in patients with severe congenital neutropenia
- Manuela Germeshausen, Karl Welte, and Matthias Ballmaier
Blood 2009; 113: 668-670.
[Abstract]
[Full text]
[PDF]
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
- Sarah Cooley, Elizabeth Trachtenberg, Tracy L. Bergemann, Koy Saeteurn, John Klein, Chap T. Le, Steven G. E. Marsh, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller, and Daniel J. Weisdorf
Blood 2009; 113: 726-732.
[Abstract]
[Full text]
[PDF]
|
|
